Literature DB >> 27986128

High Thyroid-stimulating Hormone Levels Increase Proinflammatory and Cardiovascular Markers in Patients with Extreme Obesity.

Jaime Héctor Gómez-Zamudio1, Victoria Mendoza-Zubieta2, Aldo Ferreira-Hermosillo2, Marío Antonio Molina-Ayala2, Adán Valladares-Sálgado1, Fernando Suárez-Sánchez1, Jose de Jesús Peralta-Romero1, Miguel Cruz3.   

Abstract

BACKGROUND AND AIMS: Obesity is an important health problem worldwide and many studies have suggested a relationship between obesity and thyroid function, with controversial results. Interestingly, high TSH levels have been involved with the presence of inflammatory state and risk for developing cardiovascular diseases in hypothyroid and obese patients. The aim in this work was to determine the prevalence of hypothyroidism in patients with extreme obesity and to determine whether their TSH levels were related to increased serum levels of inflammatory and cardiovascular markers.
METHODS: A cross-sectional study in 101 patients with extreme obesity (BMI ≥40) was performed. Anthropometric (weight, height and waist circumference) and biochemical (fasting glucose, glycosylated hemoglobin, triglycerides, total cholesterol, LDL-C, HDL-C and insulin) parameters were measured. TSH and FT4 levels as well as clinical exploration for diagnosis of hypothyroidism were carried out. Serum concentration of IL-10, IL-6, adiponectin, resistin, leptin, ICAM-1, VCAM-1 and E-selectin were determined.
RESULTS: A high prevalence for diabetes (37.6%), prediabetes (50.5%), dyslipidemia (74.3%), hypertension (61.4%) and hypothyroidism (48.5%) was observed in patients with extreme obesity. The presence of hypothyroidism increased serum concentration of proinflammatory cytokines IL-6 and leptin and decreased the antiinflammatory cytokine adiponectin. In addition, serum TSH levels showed a correlation for waist circumference, weight, BMI, A1c, insulin, IL-6, leptin, ICAM-1 and E-selectin.
CONCLUSION: There is a high prevalence for hypothyroidism in patients with extreme obesity. High levels of TSH contribute to elevate proinflammatory and cardiovascular risk markers, increasing the risk for development of cardiovascular diseases.
Copyright © 2016 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular markers; Extreme obesity; Hypothyroidism; TSH

Mesh:

Substances:

Year:  2016        PMID: 27986128     DOI: 10.1016/j.arcmed.2016.10.007

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  10 in total

1.  Meta-analytic evidence for increased low-grade systemic inflammation and oxidative stress in hypothyroid patients. Can levothyroxine replacement therapy mitigate the burden?

Authors:  Mariana L Tellechea
Journal:  Endocrine       Date:  2020-09-02       Impact factor: 3.633

2.  Interaction effect of obesity and thyroid autoimmunity on the prevalence of hyperthyrotropinaemia.

Authors:  Xiaoyong Guo; Zhao He; Shanshan Shao; Yilin Fu; Dongmei Zheng; Lu Liu; Ling Gao; Liying Guan; Meng Zhao; Jiajun Zhao
Journal:  Endocrine       Date:  2020-03-25       Impact factor: 3.633

3.  Identification of High-Frequency Methylation Sites in RNF180 Promoter Region Affecting Expression and Their Relationship with Prognosis of Gastric Cancer.

Authors:  Fang Han; Shuang Liu; Jingjing Jing; Hao Li; Yuan Yuan; Li-Ping Sun
Journal:  Cancer Manag Res       Date:  2020-05-13       Impact factor: 3.989

4.  Clinical Associations of Thyroid Hormone Levels with the Risk of Atherosclerosis in Euthyroid Type 2 Diabetic Patients in Central China.

Authors:  Limin Wang; Tingting Chen; Jiawei Yu; Huijuan Yuan; Xinru Deng; Zhigang Zhao
Journal:  Int J Endocrinol       Date:  2020-07-03       Impact factor: 3.257

5.  Evaluation of the Thyroid Characteristics and Correlated Factors in Hospitalized Patients with Newly Diagnosed Type 2 Diabetes.

Authors:  Yanli Li; Min Yi; Xiaoyi Deng; Wangen Li; Yimei Chen; Xiaodan Zhang
Journal:  Diabetes Metab Syndr Obes       Date:  2022-03-20       Impact factor: 3.168

6.  Impact of Weight Reduction on Thyroid Function and Nonalcoholic Fatty Liver among Egyptian Adolescents with Obesity.

Authors:  Mona Karem Amin; Ahmed Ibrahim Ali; Hesham Elsayed
Journal:  Int J Endocrinol       Date:  2022-03-29       Impact factor: 3.257

7.  Association between High Normal TSH Levels and Obesity in Women with Anti-Thyroid Autoantibodies (ATAs).

Authors:  Fernanda Velluzzi; Silvia Pisanu; Maura Galletta; Michele Fosci; Gianni Secci; Andrea Deledda; Francesco Boi; Rossella Rodia; Giuseppe Fanciulli; Alessandro Palmerio Delitala; Gianmarco Sainas; Andrea Loviselli
Journal:  J Clin Med       Date:  2022-08-31       Impact factor: 4.964

8.  Use of a Highly Antioxidant Diet in the Regulation of Adipose Tissue Secretion in Patients after the BIB Procedure.

Authors:  Edyta Balejko; Jerzy Balejko
Journal:  Foods       Date:  2021-05-17

9.  Correlation analysis of serum thyroid stimulating hormone with acute cerebrovascular disease.

Authors:  Jian Zhu; Ming Chen; Nan Li; Shaoling Yang; Lu Xu; Yanru Wang; Hong Li
Journal:  Eur J Med Res       Date:  2019-10-24       Impact factor: 2.175

10.  Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients.

Authors:  Yonghui Hu; Zhiyue Yan; Congqing Pan
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-15       Impact factor: 3.168

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.